Delivery Order SPE2DB20D1100-SPE2DB25FB5U4

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,546.59, is for the delivery of Vitamin D2 1.25MG (50,000 unit) in 100-count bottles. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with a completion date of December 5, 2024. This contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,871.95, is for the delivery of Vitamin D2 1.25mg (50,000 unit) tablets in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 11, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,720.40, is for the delivery of VITAMIN D2 1.25MG (50,000 UNIT) 100S. It is a firm fixed price contract with a completion date of December 4, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,264.63, is for the procurement of Vitamin D2 1.25mg (50,000 unit) 100s. The order has an ultimate completion date of April 10, 2025. This contract is not associated with a set-aside program and is part of AmerisourceBergen's extensive Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,509.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567584719 VITAMIN D2 1.25MG (50,000 UNIT) 100S and has an ultimate completion date of March 17, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VITAMIN D2 1.25MG (50,000 UNIT) 100S, with a ceiling value of $1,735.23 and a completion date of May 29, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, and there are no major...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,310.71, is a delivery order for 4,567,461,821 units of Vitamin D2 1.25mg (50,000 unit) 100s. The award has an ultimate completion date of March 5, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,632.86, is for the delivery of vitamin D2 tablets (4568164354 ! VIT D2 1.25MG 100S) and has a performance period through June 4, 2025. The contract is a firm-fixed-price, non-set-aside delivery order. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vitamin D2 1.25MG (50,000 unit) 100S, with a ceiling value of $1,060.45 and a completion date of March 5, 2025. The contract is a Firm Fixed Price arrangement, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,791.33, is for the delivery of Vitamin D2 1.25mg (50,000 unit) 100s. This is a firm fixed-price contract with a final completion date of February 20, 2025. The contract was awarded on February 19, 2025 and is not designated as a set-aside requirement. Amerisourcebergen Drug Corp...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB5U4
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,068.45, is for the delivery of 4567825222 - VITAMIN D2 1.25MG (50,000 UNIT) 100S. It is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/7/25, 1:14 PM